The Technical Review Panel (TRP) has completed its assessment of Round 5 proposals, and, according to the Global Fund Secretariat, has recommended proposals for board approval that will cost $726 million over the first two years. This is about three-quarters of the $1,000 million cost that was originally projected.
You are here
Global Fund Board
Over 300 organizations in 67 countries have signed the International Appeal for Full Funding of the Global Fund. This Appeal was launched two weeks ago by the three NGO board members of the Global Fund, backed by a coalition of NGOs in Europe, North America and Japan.
The Global Fund board delegation that represents "Communities Living with AIDS, TB and Malaria" is seeking a person to serve as Communications Focal Point. This position requires one quarter to one half of the chosen person's time, and is unpaid, through costs are paid for attending Global Fund board meetings.
The Global Fund has made its fiftieth decision regarding whether to approve a grant for extension beyond the first two years, known as "Phase 2 Renewal."
The Board elected Dr. Carol Jacobs of Barbados to serve as Chair for the next two years, and it elected Prof. Michel Kazatchkine to serve as Vice-Chair. They took over from Mr. Tommy Thompson, former US Secretary of Health and Human Services, and Dr. Helene Rossert, head of the French NGO AIDES, respectively, whose terms of office had expired.
In many countries, there has been considerable uncertainty regarding the extent to which the Country Coordinating Mechanism (CCM) has authority over the Principal Recipient (PR). Accordingly, the Board added to the CCM Guidelines a number of paragraphs that are supposed to clarify things.
Most board decisions are made after the topic in question has been extensively discussed by a board committee, and the committee has made a recommendation to the board. The board has now decided to revise its committee structure. The four main committees that have existed in the past have been replaced with the following three committees:
At its October 2002 meeting, the board decided that if a medicinal product is to be eligible for purchase using Global Fund grants, it must meet various requirements.
Several board members commented on the fact that at present, only $300 million of the anticipated $1,000 million cost of Round 5 has been promised. This led to a resolution saying "The Board notes with concern the current shortfall regarding funds available for Round 5. The Board calls upon participants of the Replenishment Conference, and all other potential donors, to take urgent action to ensure that Round 5 is fully funded."
As a result of pressure from the United States, the Board agreed to appoint an Inspector General. The role of the office of the inspector general will be to assess whether the Global Fund and its grant recipients are using the money in the ways intended.